Nicholas Augustinos - Jun 3, 2021 Form 4 Insider Report for DEXCOM INC (DXCM)

Role
Director
Signature
By: Jereme Sylvain For: Nicholas Augustinos
Stock symbol
DXCM
Transactions as of
Jun 3, 2021
Transactions value $
-$295,794
Form type
4
Date filed
6/7/2021, 07:35 PM
Previous filing
May 25, 2021
Next filing
Nov 2, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DXCM Common Stock Sale -$296K -806 -20.58% $366.99 3.11K Jun 3, 2021 Direct F1, F2
holding DXCM Common Stock 7.9K Jun 3, 2021 by Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 4, 2021, Mr. Augustinos adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Augustinos. The sale of shares set forth above were pursuant to the 10b5-1 Plan.
F2 Included in this number are 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.